James analyst Dane Leone maintained a Strong Buy rating and a $19.00 price target on Ocular Therapeutix (NASDAQ:OCUL), aligning with the broader analyst consensus. According to InvestingPro data, ...
Exact presentation times are subject to change. Expected presentation times can be found on the Program section of the Angiogenesis, Exudation, and Degeneration 2025 conference website. Follow the ...
The following is a summary of “Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study,” published in the January 2025 issue of Ophthalmology by ...
Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the US Patent Office (USPTO) has granted Active Biotech's US patent application 17/939,109 for laquinimod in eye disorders. "We ...
Faricimab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Non-Proliferative Diabetic Retinopathy (NPDR). According to GlobalData, Phase II drugs for ...
About 20%–50% of people with diabetes will experience diabetic gastroparesis. Gastroparesis is more common in people who have type 1 diabetes and in those who have had type 2 diabetes for more than 10 ...
This code is designed for detecting Diabetic Retinopathy in retinal fundus images using a deep learning approach. It preprocesses the images, applies data augmentation to improve model generalization, ...
The Arogya Aarohan application to assess the risk of oral cancer is just one of the few AI-driven initiatives aimed at detecting diseases like tuberculosis, diabetic retinopathy, breast cancer, ...